Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chang'an I Recipe is a Traditional Chinese Medicine (TCM) decoction used primarily for treating diarrhea-predominant irritable bowel syndrome (IBS-D). It appears to be derived from classical TCM formulations and has been studied in clinical trials to evaluate its efficacy and safety. The drug has been investigated in a multicenter, randomized, double-blind clinical trial for IBS-D treatment, registered with the identifier No.ChiCTR-TRC-09000328. According to the search results, Chang'an I Recipe demonstrated greater effectiveness than placebo in treating IBS-D, with no obvious adverse reactions reported. It is related to formulations like Chang'an II Recipe (derived from Tong-Xie-Yao-Fang), Wei Chang An pill, and Tong-xie-ning, which target similar gastrointestinal disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chang'an I Recipe.